Dallas, Texas, Feb. 29, 2020 (GLOBE NEWSWIRE) -- The global Therapeutic Nuclear Medicines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 17.2% in the forecast period of 2020 to 2025 and will expected to reach USD 2348.8 million by 2025, from USD 1243.8 million in 2019.
Request a sample of this report @ https://www.orbisresearch.com/contacts/reques...le/4177398
The driving factors influencing the Global Therapeutic Nuclear Medicines Market includes increasing initiatives to reduce the demand supply gap of Mo-99 and rising incidence of cardiac ailments and cancer. Furthermore, short-term life of radiopharmaceuticals lessens the growth of adoption, whereas hospital budget high equipment prices and cuts prices are anticipated to remain constant over the forecast period.
Geography-wise, North America hold the largest market share in 2018 owing to the increasing cases of cancer and medications across the region.
The global therapeutic nuclear medicines market is categorized into several by type overview, application overview, and procedural volume assessment, and region. Based on the type overview, the global therapeutic nuclear medicines market is fragmented into Diagnostic Nuclear Medicine, Gallium-67, Iodine-123, Technetium- 99m, SPECT Radiopharmaceuticals, PET Radiopharmaceuticals, Ru-82, F-18, Alpha Emitters, Ra-223, Beta Emitters, Yttrium-90, Lutetium-177, Rhenium-186, Beta Emitters, Cesium-131, Iridium-192, Palladium-131, and Brachytherapy Isotopes. Based on the application, the global therapeutic nuclear medicines market is divided into SPECT Applications, Cardiology, Thyroid Applications, Pulmonary Scans, Neurology, Oncology, PET Applications, Therapeutic Applications, Bone Metastasis, Endocrine Tumors, and Lymphoma. Based on the procedural volume assessment, the global therapeutic nuclear medicines market is divided into diagnostic procedures, PET procedures, SPECT procedures, alpha emitter procedures, beta emitter procedures, and brachytherapy procedures.
Looping on to the regional overview, global therapeutic nuclear medicines market is a wide range to USA, Canada, Germany, Mexico, Asia Pacific, Russia, Korea, France, India, UAE, Turkey, Argentina, North America, UK, South Africa, Europe, China, Japan, The Middle East and Africa, Italy, South America, Brazil, Saudi Arabia, Egypt, Southeast Asia, Nigeria, and Columbia.
Make an enquiry of this report @ https://www.orbisresearch.com/contacts/enquir...ng/4177398
Leading players of the global therapeutic nuclear medicines market includes Advanced Accelerator Applications (France), PharmaLogic (US), Isotopia Molecular Imaging Limited (Israel), SHINE Medical Technologies (US), Sinotau Pharmaceuticals (China), Cardinal Health (US), Eczacýbaþý-Monrol Nuclear Products (Turkey), JSC Isotope (Russia), Eckert & Ziegler (Germany), Bayer AG (Germany), GE Healthcare (US), Bracco Imaging (Italy), Institute of Isotopes Co., Ltd. (Hungary), Curium (France), Global Medical Solutions (US), Lantheus Medical Imaging (US), NorthStar Medical Radioisotopes (US), Jubilant DraxImage (Canada), NTP Radioisotopes (South Africa), and Nordion (Canada).
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Therapeutic Nuclear Medicines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Therapeutic Nuclear Medicines, with price, sales, revenue and global market share of Therapeutic Nuclear Medicines in 2018 and 2019.
Chapter 3, the Therapeutic Nuclear Medicines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Therapeutic Nuclear Medicines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Therapeutic Nuclear Medicines market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Therapeutic Nuclear Medicines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Also View: Global Pharmaceutical for Women’s Health Market
The driving factors influencing the global pharmaceutical for women’s health market includes rising government initiatives to curb population growth, increasing incidence of chronic health conditions among women, growing demand for contraceptives to prevent unintended pregnancies. Furthermore, leading players of the global pharmaceutical for women’s health market are focusing on R&D to execute the improvements and developments of products and this leads to positively drive the global pharmaceutical for women’s health market
Request a sample of this report @ https://www.orbisresearch.com/contacts/reques...le/4215737
Geography-wise, North America hold the fastest growing and the largest market share in 2018 owing to the major factors including rising median age of first-time pregnancies, postmenopausal osteoporosis, and growing healthcare spending in the US and Canada. Furthermore, due to the increasing concer regarding contraceptives in American women and the scalable access to modern contraception may propel the growth over the forecast period. At present, leading players of the global pharmaceutical for women’s health market are taking initiatives in collaborating and partnership to promote the business and spread the word in the global pharmaceutical for women’s health market.
Make an enquiry of this report @ https://www.orbisresearch.com/contacts/enquir...ng/4215737
The global pharmaceutical for women’s health market is categorized into several by drug, by application, and region. Based on the by drug, the global pharmaceutical for women’s health market is fragmented into Zometa, Minastrin 24 Fe, Premarin, ORTHO TRI-CY LO (28), EVISTA, XGEVA, Mirena, Reclast/Aclasta, NuvaRing, FORTEO, ACTONEL, and others. Based on the application, the global pharmaceutical for womens health market is divided into Contraceptives, Polycystic Ovary Syndrome, Hormonal Infertility, Endometriosis, Postmenopausal Osteoporosis, Menopause, and other applications.
Looping on to the regional overview, global pharmaceutical for women’s health market is a wide range to USA, Canada, Germany, Mexico, Asia Pacific, Russia, Korea, France, India, UAE, Turkey, Argentina, North America, UK, South Africa, Europe, China, Japan, The Middle East and Africa, Italy, South America, Brazil, Saudi Arabia, Egypt, Southeast Asia, Nigeria, and Columbia.
Leading players of the global pharmaceutical for women’s health market includes Pfizer Inc., Lupin, Apothecus Pharmaceuticals, Novartis, Johnson & Johnson, Bayer AG, Allergan, Merck & Co., Agile Therapeutics Plc., Ferring Pharmaceuticals, Mylan N.V., Lupi, and Eli Lilly and Company.
Table of Contents
Chapter One: Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pharmaceuticals for Women's Health Revenue
1.4 Market Analysis by Type
1.4.1 Global Pharmaceuticals for Women's Health Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Granules
1.4.3 Pills
1.4.4 Powder
1.4.5 Tincture
1.4.6 Tablets
1.4.7 Capsule
1.4.8 Other
1.5 Market by Application
1.5.1 Global Pharmaceuticals for Women's Health Market Share by Application: 2020 VS 2026
1.5.2 Postmenopausal Osteoporosis
1.5.3 Endometriosis
1.5.4 Polycystic Ovarian Syndrome
1.5.5 Pregnancy Disorders
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
Place a purchase order @ https://www.orbisresearch.com/contact/purchas...er/4215737
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Us: Hector Costello Senior Manager – Client Engagements 4144N Central Expressway, Suite 600, Dallas, Texas - 75204, U.S.A. Phone No.: +1 (972)-362-8199; +91 895 659 5155
